Transcatheter Interatrial Shunt Device for the Treatment of Heart Failure with Preserved Ejection Fraction (REDUCE LAP-HF i [Reduce Elevated Left Atrial Pressure in Patients with Heart Failure]): A Phase 2, Randomized, Sham-Controlled Trial

Ted Feldman, Laura Mauri, Rami Kahwash, Sheldon Litwin, Mark J. Ricciardi, Pim Van Der Harst, Martin Penicka, Peter S. Fail, David M. Kaye, Mark C. Petrie, Anupam Basuray, Scott L. Hummel, Rhondalyn Forde-Mclean, Christopher D. Nielsen, Scott Lilly, Joseph M. Massaro, Daniel Burkhoff, Sanjiv J. Shah*

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

89 Scopus citations

Fingerprint Dive into the research topics of 'Transcatheter Interatrial Shunt Device for the Treatment of Heart Failure with Preserved Ejection Fraction (REDUCE LAP-HF i [Reduce Elevated Left Atrial Pressure in Patients with Heart Failure]): A Phase 2, Randomized, Sham-Controlled Trial'. Together they form a unique fingerprint.

Medicine & Life Sciences